Abstract
Internal Medicine JournalVolume 37, Issue 7 p. 505-506 Severe palmar–plantar erythema in a patient with breast cancer receiving doxorubicin–cyclophosphamide chemotherapy M. J. Damasiewicz, M. J. Damasiewicz 1 St Vincent’s Hospital, Melbourne and2Department of Medicine, Warrnambool HospitalWarrnambool, Victoria, AustraliaSearch for more papers by this author 1,2 F. J. M. Chionh, F. J. M. Chionh 1 St Vincent’s Hospital, Melbourne and2Department of Medicine, Warrnambool HospitalWarrnambool, Victoria, AustraliaSearch for more papers by this author 1,2 T. Hayes, T. Hayes 1 St Vincent’s Hospital, Melbourne and2Department of Medicine, Warrnambool HospitalWarrnambool, Victoria, AustraliaSearch for more papers by this author 2 M. J. Damasiewicz, M. J. Damasiewicz 1 St Vincent’s Hospital, Melbourne and2Department of Medicine, Warrnambool HospitalWarrnambool, Victoria, AustraliaSearch for more papers by this author 1,2 F. J. M. Chionh, F. J. M. Chionh 1 St Vincent’s Hospital, Melbourne and2Department of Medicine, Warrnambool HospitalWarrnambool, Victoria, AustraliaSearch for more papers by this author 1,2 T. Hayes, T. Hayes 1 St Vincent’s Hospital, Melbourne and2Department of Medicine, Warrnambool HospitalWarrnambool, Victoria, AustraliaSearch for more papers by this author 2 First published: 04 June 2007 https://doi.org/10.1111/j.1445-5994.2007.01380.xCitations: 2Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume37, Issue7July 2007Pages 505-506 RelatedInformation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.